Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Wassmann

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biochemistry|July 21, 2009
Interaction of Inhibitor of DNA binding 3 (Id3) with Gut-enriched Krüppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cellsKerstin Wassmann, Cornelius F H Mueller, Ulrich M Becher, et al.
Hypertension (Dallas, Tex. : 1979)|October 27, 2004
Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass graftingPim van der Harst, Meint Volbeda, Adriaan A Voors, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2023
Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-StudyRoland E Schmieder, Sven Wassmann, Hans-Georg Predel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 31, 2024
Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseasesBurkhard Weisser, Sven Wassmann, Hans-Georg Predel, et al.
Frontiers in Cardiovascular Medicine|August 23, 2021
Inhibition of Rac1 GTPase Decreases Vascular Oxidative Stress, Improves Endothelial Function, and Attenuates Atherosclerosis Development in MiceSebastian Zimmer, Philip Roger Goody, Matthias Oelze, et al.
International Journal of Cardiology|March 8, 2014
Distinct CD11b+-monocyte subsets accelerate endothelial cell recovery after acute and chronic endothelial cell damageUlrich M Becher, Lisa Möller, Vedat Tiyerili, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 24, 2024
Management of dyslipidaemia in patients with comorbidities-facing the challengeLisa Frühwald, Peter Fasching, Dobromir Dobrev, et al.
Hypertension (Dallas, Tex. : 1979)|August 10, 2011
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regenerationCathleen Endtmann, Talin Ebrahimian, Thomas Czech, et al.
Integrated Blood Pressure Control|March 7, 2022
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-StudyThomas Wilke, Burkhard Weisser, Hans-Georg Predel, et al.
Circulation|May 29, 2008
Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 exportCornelius F H Mueller, Kerstin Wassmann, Julian D Widder, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biochemistry|July 21, 2009
Interaction of Inhibitor of DNA binding 3 (Id3) with Gut-enriched Krüppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cellsKerstin Wassmann, Cornelius F H Mueller, Ulrich M Becher, et al.
Hypertension (Dallas, Tex. : 1979)|October 27, 2004
Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass graftingPim van der Harst, Meint Volbeda, Adriaan A Voors, et al.
Hypertension (Dallas, Tex. : 1979)|March 29, 2023
Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-StudyRoland E Schmieder, Sven Wassmann, Hans-Georg Predel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 31, 2024
Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseasesBurkhard Weisser, Sven Wassmann, Hans-Georg Predel, et al.
Frontiers in Cardiovascular Medicine|August 23, 2021
Inhibition of Rac1 GTPase Decreases Vascular Oxidative Stress, Improves Endothelial Function, and Attenuates Atherosclerosis Development in MiceSebastian Zimmer, Philip Roger Goody, Matthias Oelze, et al.
International Journal of Cardiology|March 8, 2014
Distinct CD11b+-monocyte subsets accelerate endothelial cell recovery after acute and chronic endothelial cell damageUlrich M Becher, Lisa Möller, Vedat Tiyerili, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 24, 2024
Management of dyslipidaemia in patients with comorbidities-facing the challengeLisa Frühwald, Peter Fasching, Dobromir Dobrev, et al.
Hypertension (Dallas, Tex. : 1979)|August 10, 2011
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regenerationCathleen Endtmann, Talin Ebrahimian, Thomas Czech, et al.
Integrated Blood Pressure Control|March 7, 2022
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-StudyThomas Wilke, Burkhard Weisser, Hans-Georg Predel, et al.
Circulation|May 29, 2008
Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 exportCornelius F H Mueller, Kerstin Wassmann, Julian D Widder, et al.
Pageof 8